Cao et al. found that oral administration of quinoa polysaccharide mitigated dyslipidemia and reduced hepatic lipid accumulation by decreasing the contents of TG, LDL-C, glutamic oxaloacetic transaminase (AST), glutamic pyruvic transaminase (ALT), and malondialdehyde (MDA). This evidence concerns the gene GPT and metabolic syndrome.